Cargando…

CS16.2 Improving survival in patients with decompensated cirrhosis

Detalles Bibliográficos
Autor principal:	Amarapurkar, D.N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129939/ http://dx.doi.org/10.1016/S1201-9712(11)60053-2

Ejemplares similares

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease
por: Punamiya, Sundeep J., et al.
Publicado: (2011)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Antiviral Therapy in Chronic Hepatitis C Virus-related Decompensated Liver Cirrhosis – A Tightrope Walk
por: Amarapurkar, Deepak N.
Publicado: (2010)

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis
por: McPhail, Mark J.W., et al.
Publicado: (2016)

CS16.1 Management of the complications of liver cirrhosis
por: You, H.
Publicado: (2011)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis
por: Behera, Manas Kumar, et al.
Publicado: (2021)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
por: Shailesh, F. N. U., et al.
Publicado: (2014)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Impact of Bacterial Translocation on Sarcopenia in Patients with Decompensated Cirrhosis
por: Tsien, Cynthia, et al.
Publicado: (2019)

Impact of COVID-19 on Patients with Decompensated Liver Cirrhosis
por: Moga, Tudor Voicu, et al.
Publicado: (2023)

Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis
por: Chouik, Yasmina, et al.
Publicado: (2023)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
por: Kandula, Manasa, et al.
Publicado: (2016)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis
por: Tocia, Cristina, et al.
Publicado: (2020)

Cryptococcal Peritonitis in a Patient with Decompensated Liver Cirrhosis
por: Libera, Robert, et al.
Publicado: (2023)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Effect of replenishment of vitamin D on survival in patients with decompensated liver cirrhosis: A prospective study
por: Jha, Ashish Kumar, et al.
Publicado: (2017)

Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis
por: Uemura, Masahito, et al.
Publicado: (2011)

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
por: Xiao, Yong, et al.
Publicado: (2020)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

Implementation of a ‘care bundle’ improves the management of patients admitted to hospital with decompensated cirrhosis
por: Dyson, J. K., et al.
Publicado: (2016)

Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis
por: Barakat, Ashraf Abd El-Khalik, et al.
Publicado: (2015)

Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
por: Zanetto, Alberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_912ljbiubqr664vens24bgetmn